31-12-2021, 08:39 AM
"We were sent interesting results (from Chile's top health authority) in terms of adverse events in children," Health Surveillance Director Maria Antonieta Gamarra said in a Ministry statement.
"Now, the approval of Sinhoparm is in progress, we are awaiting reports from Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) to finalize its approval," she added.
https://www.riotimesonline.com/brazil-ne...rs-of-age/
"Now, the approval of Sinhoparm is in progress, we are awaiting reports from Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) to finalize its approval," she added.
https://www.riotimesonline.com/brazil-ne...rs-of-age/